{"notes_translated":{"fr":"Les examens du plan de gestion des risques protègent les Canadiens des dangers évitables et contribuent à un dialogue efficace avec les partenaires et les intervenants - compte tenu de la dépendance du ministère à l'égard de la responsabilité partager. Cet indicateur mesure l’efficacité après la commercialisation en permettant aux Canadiens d’avoir accès à des produits de santé d’un moyen efficaces et de qualité en temps opportun. Les examens des plans de gestion des risques constituent un élément important de l’amélioration de la santé et de la sécurité des Canadiens.","en":"Risk Management Plan reviews protect Canadians from preventable hazards, and contribute to effective engagement with partners and stakeholders - in view of the department's reliance on shared responsibilities. This indicator measures post-market effectiveness in providing Canadians with access to safe, effective and quality health products in a timely manner. Risk Management Plan reviews are an important component of improving the health and safety of Canadians."},"imso_approval":"true","maintainer":null,"creator":"","association_type":[],"org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"contributor":{"fr":"","en":""},"frequency":"P1Y","keywords":{"fr":["gestion des risques","décisions relatives aux nouveaux médicaments","normes de service"],"en":["risk management","new drug decisions","service standards"]},"data_series_issue_identification":{"fr":"","en":""},"ready_to_publish":"true","id":"575504e5-0358-4309-b988-ca687b2f8b0a","metadata_created":"2019-12-05T16:02:32.562573","subject":["health_and_safety"],"spatial_representation_type":[],"metadata_modified":"2019-12-05T16:02:32.562581","author":null,"author_email":null,"geographic_region":[],"position_name":{},"portal_release_date":"2019-12-05","digital_object_identifier":"","state":"active","version":null,"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Examens du plan de gestion des risques pour les décisions relatives aux nouveaux médicaments effectués conformément aux normes de service","en":"Risk Management Plan reviews for new drug decisions completed within service standards"},"type":"dataset","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"575504e5-0358-4309-b988-ca687b2f8b0a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e5ff29f5-8291-4721-9d23-a7e133709c66","related_relationship":"","name_translated":{"fr":"Pourcentage de révision du plan de gestion des risques pour les décisions relatives aux nouveaux médicaments achevées dans le respect de la norme de service","en":"Percentage of Risk Management Plan review for new drug decisions completed within service standard "},"hash":"","description":"","format":"CSV","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Percentage of Risk Management Plan review for new drug decisions completed within service standard ","language":["en","fr"],"created":"2019-12-05T16:02:35.301211","url":"http://health.canada.ca/apps/open-data/rmp-pgr/pct-list-rmp-nds-liste-pgr-pdn.csv","last_modified":null,"resource_type":"dataset","position":0,"revision_id":"b18e67a2-b301-40cd-8867-7234a92ee1c7","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"575504e5-0358-4309-b988-ca687b2f8b0a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"07fe285b-5e61-484d-92da-87fdd3a61e2c","related_relationship":"","name_translated":{"fr":"Examen du Plan de gestion des risques pour les décisions concernant les nouveaux médicaments, complété avec les normes de service Acronyme","en":"Risk Management Plan review for new drug decisions completed with service standards Acronym"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Risk Management Plan review for new drug decisions completed with service standards Acronym","language":["en"],"created":"2019-12-05T16:02:35.301220","url":"https://health.canada.ca/en/open-information/r049465-1119-6484/acronym","last_modified":null,"resource_type":"terminology","position":1,"revision_id":"b18e67a2-b301-40cd-8867-7234a92ee1c7","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"575504e5-0358-4309-b988-ca687b2f8b0a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ab81d554-fd29-4747-bbbb-cc40fd8ba505","related_relationship":"","name_translated":{"fr":"Examen du Plan de gestion des risques pour les décisions concernant les nouveaux médicaments, complété avec les normes de service Acronyme","en":"Risk Management Plan review for new drug decisions completed with service standards Acronym"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Risk Management Plan review for new drug decisions completed with service standards Acronym","language":["fr"],"created":"2019-12-05T16:02:35.301224","url":"https://health.canada.ca/fr/open-information/r049465-1119-6484/acronym","last_modified":null,"resource_type":"terminology","position":2,"revision_id":"b18e67a2-b301-40cd-8867-7234a92ee1c7","data_quality":[]}],"place_of_publication":[],"metadata_contact":{},"num_resources":3,"topic_category":[],"tags":[],"spatial":"","collection":"primary","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2019-11-14 00:00:00","display_flags":[],"groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"575504e5-0358-4309-b988-ca687b2f8b0a","isopen":false,"url":null,"notes":"Risk Management Plan reviews protect Canadians from preventable hazards, and contribute to effective engagement with partners and stakeholders - in view of the department's reliance on shared responsibilities. This indicator measures post-market effectiveness in providing Canadians with access to safe, effective and quality health products in a timely manner. Risk Management Plan reviews are an important component of improving the health and safety of Canadians.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","audience":[],"license_url":"http://open.canada.ca/en/open-government-licence-canada","program_page_url":{"fr":"","en":""},"title":"Risk Management Plan reviews for new drug decisions completed within service standards","revision_id":"b18e67a2-b301-40cd-8867-7234a92ee1c7"}